Jmcgh and Other Sites: Urine Sites Only
Numbers are percent susceptible
|
Gram Negative Organisms |
No.of isolates |
amk |
am/s |
cz |
fep |
caz |
cx |
esbl (+) |
etp |
gm |
le |
nit |
pip/ taz |
tmp/ smx |
|
Acinetobacter baumannii |
25* |
- |
92 |
- |
56 |
56 |
- |
- |
- |
68 |
68 |
- |
- |
56 |
|
Citrobacter freundii |
53 |
100 |
- |
0 |
100 |
77 |
79 |
- |
100 |
91 |
89 |
92 |
- |
79 |
|
Citrobacter koseri |
38 |
100 |
- |
87 |
100 |
95 |
97 |
- |
100 |
97 |
58 |
55 |
- |
68 |
|
Enterobacter aerogenes |
34 |
100 |
- |
0 |
97 |
88 |
88 |
- |
100 |
100 |
97 |
6 |
- |
97 |
|
Enterobacter cloacae |
113 |
100 |
- |
0 |
94 |
40 |
46 |
- |
72 |
87 |
58 |
12 |
- |
73 |
|
Escherichia coli |
2963 |
100 |
43 |
81 |
90 |
88 |
89 |
10 |
100 |
80 |
45 |
88 |
- |
58 |
|
Klebsiella oxytoca |
37 |
100 |
78 |
78 |
97 |
97 |
97 |
11 |
100 |
97 |
100 |
62 |
- |
97 |
|
Klebsiella pneumoniae |
513 |
99 |
87 |
95 |
97 |
96 |
97 |
3 |
100 |
98 |
96 |
30 |
- |
91 |
|
Morganella morganii |
105 |
100 |
0 |
0 |
98 |
50 |
92 |
- |
100 |
74 |
62 |
0 |
- |
31 |
|
Proteus mirabilis |
1141 |
100 |
67 |
87 |
96 |
96 |
96 |
- |
100 |
80 |
30 |
0 |
- |
35 |
|
Providencia stuartii |
114 |
99 |
0 |
0 |
100 |
96 |
100 |
- |
- |
52 |
16 |
0 |
- |
41 |
|
Pseudomonas aeruginosa |
469 |
96 |
- |
- |
72 |
71 |
- |
- |
- |
75 |
46 |
- |
83 |
- |
|
Serratia marcescens |
40 |
95 |
0 |
0 |
100 |
95 |
98 |
- |
100 |
85 |
78 |
0 |
- |
85 |
|
Stenotrophomonas maltophilia |
20/13(le)* |
- |
- |
- |
- |
- |
- |
- |
- |
- |
54 |
- |
- |
90 |
*NO. of isolates-“Percent susceptible for each
organism/antimicrobial combination was generated by including the first isolate
of that organism recovered from a given patient.” When fewer that 30 isolates
are reported it should be noted that less than statistical validity of the
estimates of percent susceptibility exist.
Abbreviation Key: amk- amikacin,
am/s-ampicillin/sulbactam, cz-cefazolin,
fep- cefepime, caz-ceftazidime,
cx-ceftriaxone, Esbl-Extended Spectrum
Beta Lactamase, etp-ertapenem, gm-gentamicin, le-levofloxacin,
nit-nitrofurantoin, pip/taz-piperacillin/tazobactam, tmp.smx-trimethoprim/sulfa
- antibiotics not tested or not recommended
due to lack of correlation between in vitro results and in vivo activity.